Author

Fatemeh Saberi Hosnijeh

Observed names: F Saberi Hosnijeh, F, Saberi Hosnijeh, F. Hosnijeh, F. Saberi Hosnijeh, F. Saberi-Hosnije, F. Saberi-Hosnijeh, FS Hosnijeh, Fatemeh S. Hosnijeh, Fatemeh Saberi Hosnijeh1, Fatemeh Saberi-Hosnijeh, HOSNIJEH FS, Hosnijeh, Fatemeh Saberi, Saberi Hosnijeh, F., Saberi Hosnijeh, Fatemeh

Observed institutions: Zanjan University of Medical Sciences, Utrecht University, Leiden University Medical Center, Erasmus MC, University Medical Center Utrecht, National Institute for Public Health and the Environment, Italian institute for Genomic Medicine, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Imperial College London, University of Naples Federico II, Erasmus University Rotterdam, University of Zanjan

ORCID: 0000-0002-7572-9715

Observed ORCID: 0000-0002-7572-9715

OpenAlex ID: A5087941141

Cam Deformity and Acetabular Dysplasia as Risk Factors for Hip Osteoarthritis

2016 · Fatemeh Saberi Hosnijeh, Maria E. Zuiderwijk, et al. · Arthritis & Rheumatology · 162

Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort

2016 · Fatemeh Saberi Hosnijeh, Anne Sofie Siebuhr, et al. · Arthritis Research & Therapy · 126

PDF

Osteoarthritis year in review 2018: biomarkers (biochemical markers)

2018 · F. Saberi Hosnijeh, S.M. Bierma-Zeinstra, et al. · Osteoarthritis and Cartilage · 88

PDF

Biomarkers for osteoarthritis: Can they be used for risk assessment? A systematic review

2015 · Fatemeh Saberi Hosnijeh, Jos Runhaar, et al. · Maturitas · 70

Immunologic profile of excessive body weight

2011 · Mansour Taghavi Azar Sharabiani, Roel Vermeulen, et al. · Biomarkers · 61

Plasma Cytokines and Future Risk of Non-Hodgkin Lymphoma (NHL): A Case-Control Study Nested in the Italian European Prospective Investigation into Cancer and Nutrition

2010 · Fatemeh Saberi Hosnijeh, Esmeralda J.M. Krop, et al. · Cancer Epidemiology Biomarkers & Prevention · 60

Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort

2014 · Fatemeh Saberi Hosnijeh, Qing Lan, et al. · Blood · 58

A life course approach to explore the biological embedding of socioeconomic position and social mobility through circulating inflammatory markers

2016 · Raphaële Castagné, Cyrille Delpierre, et al. · Scientific Reports · 56

PDF

The association between genetically elevated polyunsaturated fatty acids and risk of cancer

2023 · Philip C. Haycock, Maria Carolina Borges, et al. · EBioMedicine · 53

PDF

Development of a prediction model for future risk of radiographic hip osteoarthritis

2018 · F. Saberi Hosnijeh, M. Kavousi, et al. · Osteoarthritis and Cartilage · 51

PDF

The intake of grain fibers modulates cytokine levels in blood

2011 · Shu-Chun Chuang, Roel Vermeulen, et al. · Biomarkers · 46

High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis

2021 · P. Martijn Kolijn, Fatemeh Saberi Hosnijeh, et al. · Blood · 45

Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects

2009 · Fatemeh Saberi Hosnijeh, Esmeralda J. M. Krop, et al. · Biomarkers · 45

Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis

2014 · M. Chadeau-Hyam, R.C.H. Vermeulen, et al. · Annals of Oncology · 42

PDF

Omics for prediction of environmental health effects: Blood leukocyte-based cross-omic profiling reliably predicts diseases associated with tobacco smoking

2016 · Panagiotis Georgiadis, Dennie G. Hebels, et al. · Scientific Reports · 38

PDF

Serum levels of hsa‐miR‐16‐5p, hsa‐miR‐29a‐3p, hsa‐miR‐150‐5p, hsa‐miR‐155‐5p and hsa‐miR‐223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

2020 · Delphine Casabonne, Yolanda Benavente, et al. · International Journal of Cancer · 35

PDF

Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study

2014 · Fatemeh Saberi Hosnijeh, Giuseppe Matullo, et al. · International Journal of Cancer · 30

PDF

Circulating Soluble CD30 and Future Risk of Lymphoma; Evidence from Two Prospective Studies in the General Population

2011 · Roel Vermeulen, Fatemeh Saberi Hosnijeh, et al. · Cancer Epidemiology Biomarkers & Prevention · 30

Dietary Intakes and Risk of Lymphoid and Myeloid Leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)

2013 · Fatemeh Saberi Hosnijeh, Petra Peeters, et al. · Nutrition and Cancer · 27

Serum metabolomic pertubations among workers exposed to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD)

2013 · Fatemeh Saberi Hosnijeh, Alexandros Pechlivanis, et al. · Environmental and Molecular Mutagenesis · 26

Soluble B‐cell activation marker of sCD27 and sCD30 and future risk of B‐cell lymphomas: A nested case‐control study and meta‐analyses

2015 · Fatemeh Saberi Hosnijeh, Lutzen Portengen, et al. · International Journal of Cancer · 25

PDF

Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases

2017 · Aristotelis Chatziioannou, Panagiotis Georgiadis, et al. · Scientific Reports · 22

PDF

Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)

2013 · Fatemeh Saberi Hosnijeh, Isabelle Romieu, et al. · Cancer Causes & Control · 21

Occupation and risk of lymphoid and myeloid leukaemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)

2013 · Fatemeh Saberi Hosnijeh, Yvette Christopher, et al. · Occupational and Environmental Medicine · 20

Association between anthropometry and lifestyle factors and risk of B‐cell lymphoma: An exposome‐wide analysis

2020 · Fatemeh Saberi Hosnijeh, Delphine Casabonne, et al. · International Journal of Cancer · 19

PDF

Works count: 97

Citation count: 1,460

H-index: 22

I10-index: 37